www.hvtn.org Open in urlscan Pro
52.40.41.147  Public Scan

Form analysis
1 forms found in the DOM

Name: hvtn-newsletter-sign-up — POST /bin/fhcrc/form

<form data-elastic-exclude="" method="POST" action="/bin/fhcrc/form" id="new_form" name="hvtn-newsletter-sign-up" enctype="multipart/form-data" class="aem-Grid aem-Grid--5 aem-Grid--tablet--12 aem-Grid--default--5 aem-Grid--phone--12">
  <script src="https://www.google.com/recaptcha/api.js?onload=loadCaptchaCallback&amp;render=6LepebYUAAAAABR5hUFpdi_d3KERmfzPv4flwoFD" nonce="6f950aa5-99a3-4a58-bf60-4af092354c59"></script>
  <script nonce="6f950aa5-99a3-4a58-bf60-4af092354c59">
    if (!window.fh) {
      window.fh = {};
    }
    window.fh.form_name = 'hvtn-newsletter-sign-up';
    window.fh.action = 'hvtn_newsletter_sign_up';
    window.fh.site_key = '6LepebYUAAAAABR5hUFpdi_d3KERmfzPv4flwoFD';
  </script>
  <input type="hidden" name=":formstart" value="/content/hvtn/en/jcr:content/root/container/container_1609261618">
  <input type="hidden" name=":formname" value="hvtn-newsletter-sign-up">
  <input type="hidden" name=":redirect" value="/content/hvtn/en/thank-you.html">
  <script src="/etc.clientlibs/common/clientlibs/js/libs/jquery.min.2f6b11a7e914718e0290410e85366fe9.js"></script>
  <script src="/etc.clientlibs/common/clientlibs/js/libs/jquery-ui.min.e4dfd218ad4c061bd1d218d801436a1e.js"></script>
  <script src="/etc.clientlibs/common/components/omni/content/form/formcontainer/clientlibs.min.8a89ca2500af7e24a85c44510e1a8372.js"></script>
  <input type="hidden" name="c_token" id="recaptchaToken">
</form>

Text Content

"HVTN" "HVTN"
 * About
   * About HVTN Leadership Senior Staff Scientific Achievements
 * Scientific Programs
   * Scientific Programs Overview HVTN Trials Integrated Science Infographic
     Scholar Grants How To Apply RAMP Scholar Profiles Scientific Publications
     Ancillary Studies Policy Scientific Leadership Development Award
 * Participate
   * Participate Overview Study Clinics The Right HIV Test Information for
     Providers Participants' Rights
 * Community
   * Community Overview Good Participatory Practice Community Advisory Board
     HVTN Faith Initiative Community Compass Past Publications
 * HIV Study Basics
   * HIV Study Basics Overview Key HIV Vaccine Topics Types of Vaccines How
     Vaccines Work How HVTN Study Protocols are Developed Using Antibodies for
     HIV Prevention Ethics of HVTN Trials HIV Vaccine Myths and Facts HIV
     Awareness HIV Resources & Links
 * News
   * HVTN News News Releases For The Media

Events
Careers
Contact Us


   
 * About
   * About HVTN
   * Leadership
   * Senior Staff
   * Scientific Achievements
   
   
 * Scientific Programs
   * Scientific Programs Overview
     HVTN Trials
     Integrated Science Infographic
   * Scholar Grants
     How To Apply
     RAMP Scholar Profiles
   * Scientific Publications
     Ancillary Studies Policy
   * Scientific Leadership Development Award
   
   
 * Participate
   * Participate Overview
   * Study Clinics
   * The Right HIV Test
     Information for Providers
   * Participants' Rights
   
   
 * Community
   * Community Overview
     Good Participatory Practice
     Community Advisory Board
     HVTN Faith Initiative
   * Community Compass
     Past Publications
   
   
 * HIV Study Basics
   * HIV Study Basics Overview
   * Key HIV Vaccine Topics
     Types of Vaccines
     How Vaccines Work
     How HVTN Study Protocols are Developed
     Using Antibodies for HIV Prevention
     Ethics of HVTN Trials
   * HIV Vaccine Myths and Facts
   * HIV Awareness
   * HIV Resources & Links
   
   
 * News
   * HVTN News
   * News Releases
   * For The Media
   

Events
Careers
Contact Us

AN HIV VACCINE


THE WORLD'S BEST LONG-TERM HOPE FOR ENDING AIDS

The HVTN uses an integrated approach to HIV prevention to advance the fields of
vaccinology, social and behavioral sciences, statistics, and immunology, as well
as COVID-19 and tuberculosis (TB) vaccines.  

Learn More

70+


STUDY SITES

Headquartered at Fred Hutch in Seattle, the Network includes over 70 sites on
four continents staffed by teams with expertise in vaccinology, immunology, and
in conducting clinical trials.

100+


CLINICAL TRIALS

For more than 20 years, the HVTN has conducted all phases of clinical trials
based on the latest developments in vaccinology and immunology for the
prevention of HIV, tuberculosis and COVID-19.

95+


SCHOLAR AWARDS

We are investing in the next generation of HIV prevention researchers with
grants and mentoring for African American/Black, Hispanic/Latinx, Native
American/American Indian/Alaska Native, Native Hawaiian, Asian and Pacific
Islander medical students.


HVTN MISSION

Our mission is to fully characterize the safety, immunogenicity, and efficacy of
HIV vaccine candidates with the goal of developing a safe, effective vaccine as
rapidly as possible for prevention of HIV globally.


WHO WE ARE

We are the world’s largest publicly-funded international collaboration focused
on the evaluation of vaccines to prevent HIV/AIDS.



WHAT WE DO

Our sites conduct all phases of clinical trials — from evaluating early phase
vaccines for safety and immunogenicity to testing vaccine efficacy. 


GET INVOLVED

Worldwide, thousands of people have participated in HIV vaccine trials.
Volunteers are the heroes of vaccine development.

More About HVTN
INTERNATIONAL Sites


IT TAKES A VILLAGE

The HIV Vaccine Trials Network is an international partnership of research
scientists, clinical trial sites, laboratories, statisticians, regulators and
ethicists, participants, volunteers and community representatives working with
industry, academia, and governments in the global search for a preventive HIV
vaccine.

View The Interactive Map


RECENT HVTN NEWS & ANNOUNCEMENTS


MEET THE 2024 SCIENTIFIC LEADERSHIP DEVELOPMENT (SLD) AWARDEES

The 3rd cohort of SLD awardees has been selected for a year-long mentored
project starting in 2024. Please join the HVTN in congratulating these emerging
leaders.


A STATEMENT FROM THE HVTN ON THE PREPVACC STUDY ANNOUNCEMENT

PrEPVacc announced that vaccinations have been stopped in its HIV Phase 2
prevention study of experimental vaccine regimens running in East and Southern
Africa due to lack of demonstrated efficacy in preventing HIV acquisition.


READ THE LATEST COMMUNITY COMPASS ISSUE

This issue of Community Compass serves as a celebration of the legacy and life
of Dr. Wallace. While his presence is missed, his work continues. 

HVTN coverage from its home institution — Fred Hutch


NEWS ON HVTN

Read More
A promising HIV vaccine candidate gets a little help New strategy stirs a robust
response from T cells tracked by McElrath lab May 24, 2023
Year in Pictures: 2022 A look back at the year through compelling images
December 12, 2022
Could a 100-year-old TB vaccine help scientists find a better one? Harmless
vaccine BCG is made of living bacteria; in tests might serve as a proxy for
deadly tuberculosis December 12, 2022
Dr. Larry Corey receives Alexander Fleming Award Virologist honored by peers for
his lifetime achievements against infectious diseases October 21, 2022
SCHOLAR AWARDS


RAMP SCHOLAR GRANT

The Research and Mentorship Program (RAMP) provides structured mentorship and
project funding to African American/Black, Hispanic/Latinx, Native
American/American Indian/Alaska Native, Native Hawaiian, Asian and Pacific
Islander medical students in areas of basic, clinical behavioral, laboratory and
social sciences.

Learn More



 

 * HVTN Lab Portal
 * HVTN Members
 * HelpEndHIV.org

 * Terms of Use & Privacy Policy
 * Conflict of Interest
 * Accountability & Impact
 * Site Map

--------------------------------------------------------------------------------

© 2024 Fred Hutchinson Cancer Center, a 501(c)(3) nonprofit organization 1100
Fairview Ave. N., P.O. Box 19024, Seattle, WA 98109-1024 Contact Us
 * 
 * 
 * 
 *